| 1 |
34385241 | A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design. | 2021 Aug 12 |
4 |
| 2 |
34885192 | Measurement of the Drug Sensitivity of Single Prostate Cancer Cells. | 2021 Dec 2 |
2 |
| 3 |
28117385 | Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. | 2017 Jun |
3 |
| 4 |
28614217 | PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study. | 2017 Jun |
4 |
| 5 |
25131864 | [Enzalutamide-a novel androgen receptor inhibitor that provides treatment options for patients with castration-resistant prostate cancer]. | 2014 Jul |
2 |